The latest financial statement is for the quarter ending 2025-09-30.
| Cash Flow | 2025-09-30 |
|---|---|
| Net loss | -39,309 |
| Net change in prepaid expenses | 1,487 |
| Net cash used in operating activities | -40,796 |
| Loans from related parties | 45,000 |
| Net cash provided by financing activities | 45,000 |
| Net change in cash | 4,204 |
| Cash and cash equivalents at beginning of period | 2,083 |
| Cash and cash equivalents at end of period | 6,287 |
NIKA PHARMACEUTICALS, INC (NIKA)
NIKA PHARMACEUTICALS, INC (NIKA)